Diabetic Kidney Disease in Post-Kidney Transplant Patients

被引：3

作者：

Pham, Ngoc-Yen T. ^{[1
]}

Cruz, Diego ^{[2
]}

Madera-Marin, Luis ^{[1
]}

Ravender, Raja ^{[1
]}

Garcia, Pablo ^{[1
]}

机构：

[1] Univ New Mexico, Sch Med, Div Nephrol, Albuquerque, NM 87106 USA

[2] Hosp Gen San Juan Dios, Guatemala City 01001, Guatemala

来源：

JOURNAL OF CLINICAL MEDICINE | 2024年 / 13卷 / 03期

关键词：

PTDM; kidney transplant; diabetic nephropathy; diabetes; BASAL INSULIN THERAPY; LONG-TERM; RENAL-TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; CARDIOVASCULAR OUTCOMES; GLUCOSE-METABOLISM; RAPAMYCIN TOXICITY; MTOR INHIBITION; UNITED-STATES; DOUBLE-BLIND;

D O I：

10.3390/jcm13030793

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Post-transplant diabetes mellitus (PTDM) is a common occurrence in post-kidney transplantation and is associated with greater mortality, allograft failure, and increased risk of infections. The primary goal in the management of PTDM is to achieve glycemic control to minimize the risk of complications while balancing the need for immunosuppression to maintain the health of the transplanted kidney. This review summarizes the effects of maintenance immunosuppression and therapeutic options among kidney transplant recipients. Patients with PTDM are at increased risk of diabetic kidney disease development; therefore, in this review, we focus on evidence supporting the use of novel antidiabetic agents and discuss their benefits and potential side effects in detail.

引用

页数：18

共 110 条

[21] Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) [J].

de Boer, Ian H. ;

Khunti, Kamlesh ;

Sadusky, Tami ;

Tuttle, Katherine R. ;

Neumiller, Joshua J. ;

Rhee, Connie M. ;

Rosas, Sylvia E. ;

Rossing, Peter ;

Bakris, George .

DIABETES CARE, 2022, 45 (12) :3075-3090

[22] Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats [J].

Deblon, N. ;

Bourgoin, L. ;

Veyrat-Durebex, C. ;

Peyrou, M. ;

Vinciguerra, M. ;

Caillon, A. ;

Maeder, C. ;

Fournier, M. ;

Montet, X. ;

Rohner-Jeanrenaud, F. ;

Foti, M. .

BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (07) :2325-2340

[23] Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes? [J].

Di Paolo, Salvatore ;

Teutonico, Annalisa ;

Leogrande, Domenica ;

Capobianco, Carmen ;

Schena, Paolo F. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2236-2244

[24]

Donihi Amy Calabrese, 2006, Endocr Pract, V12, P358

[25] Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients [J].

Engels, Eric A. ;

Pfeiffer, Ruth M. ;

Fraumeni, Joseph F., Jr. ;

Kasiske, Bertram L. ;

Israni, Ajay K. ;

Snyder, Jon J. ;

Wolfe, Robert A. ;

Goodrich, Nathan P. ;

Bayakly, A. Rana ;

Clarke, Christina A. ;

Copeland, Glenn ;

Finch, Jack L. ;

Fleissner, Mary Lou ;

Goodman, Marc T. ;

Kahn, Amy ;

Koch, Lori ;

Lynch, Charles F. ;

Madeleine, Margaret M. ;

Pawlish, Karen ;

Rao, Chandrika ;

Williams, Melanie A. ;

Castenson, David ;

Curry, Michael ;

Parsons, Ruth ;

Fant, Gregory ;

Lin, Monica .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17) :1891-1901

[26] The high incidence of steroid-induced hyperglycaemia in hospital [J].

Fong, Ashley C. ;

Cheung, N. Wah. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 99 (03) :277-280

[27] Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial [J].

Gerstein, Hertzel C. ;

Colhoun, Helen M. ;

Dagenais, Gilles R. ;

Diaz, Rafael ;

Lakshmanan, Mark ;

Pais, Prem ;

Probstfield, Jeffrey ;

Riesmeyer, Jeffrey S. ;

Riddle, Matthew C. ;

Ryden, Lars ;

Xavier, Denis ;

Atisso, Charles Messan ;

Dyal, Leanne ;

Hall, Stephanie ;

Rao-Melacini, Purnima ;

Wong, Gloria ;

Avezum, Alvaro ;

Basile, Jan ;

Chung, Namsik ;

Conget, Ignacio ;

Cushman, William C. ;

Franek, Edward ;

Hancu, Nicolae ;

Hanefeld, Markolf ;

Holt, Shaun ;

Jansky, Petr ;

Keltai, Matyas ;

Lanas, Fernando ;

Leiter, Lawrence A. ;

Lopez-Jaramillo, Patricio ;

Cardona Munoz, Ernesto German ;

Pirags, Valdis ;

Pogosova, Nana ;

Raubenheimer, Peter J. ;

Shaw, Jonathan E. ;

Sheu, Wayne H-H ;

Temelkova-Kurktschiev, Theodora .

LANCET, 2019, 394 (10193) :121-130

[28] Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens [J].

Gyurus, E. ;

Kaposztas, Z. ;

Kahan, B. D. .

TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) :1583-1592

[29] Efficacy and Safety of Vildagliptin in New-Onset Diabetes After Kidney Transplantation-A Randomized, Double-Blind, Placebo-Controlled Trial [J].

Haidinger, M. ;

Werzowa, J. ;

Hecking, M. ;

Antlanger, M. ;

Stemer, G. ;

Pleiner, J. ;

Kopecky, C. ;

Kovarik, J. J. ;

Doeller, D. ;

Pacini, G. ;

Saeemann, M. D. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (01) :115-123

[30]

Hakeam HA, 2008, ANN TRANSPL, V13, P46

← 1 2 3 4 5 6 7 8 9 10 →